Goldman Sachs Group Inc Wave Life Sciences Ltd. Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,125,137 shares of WVE stock, worth $14.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,125,137

Previous 1,007,081 111.02%

Holding current value

$14.7 Million

Previous $6.55 Million 134.07%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$6.66 - $10.15 $7.45 Million - $11.3 Million	1,118,056 Added 111.02%	2,125,137 $15.3 Million
Q2 2025 Aug 14, 2025	BUY	$5.48 - $8.1 $2.46 Million - $3.64 Million	449,437 Added 80.6%	1,007,081 $6.55 Million
Q1 2025 May 09, 2025	BUY	$8.08 - $13.51 $166,641 - $278,630	20,624 Added 3.84%	557,644 $4.51 Million
Q4 2024 Feb 11, 2025	BUY	$8.0 - $16.44 $1.3 Million - $2.67 Million	162,657 Added 43.45%	537,020 $6.64 Million
Q3 2024 Nov 14, 2024	BUY	$5.12 - $9.01 $713,891 - $1.26 Million	139,432 Added 59.35%	374,363 $3.07 Million

Q2 2024 Aug 13, 2024	SELL	$4.38 - $6.48 $463,171 - $685,240	-105,747 Reduced 31.04%	234,931 $1.17 Million
Q1 2024 May 15, 2024	SELL	$3.54 - $6.84 $178,607 - $345,105	-50,454 Reduced 12.9%	340,678 $2.1 Million
Q4 2023 Feb 13, 2024	BUY	$4.16 - $6.87 $205,246 - $338,952	49,338 Added 14.44%	391,132 $1.98 Million
Q3 2023 May 14, 2024	SELL	$3.56 - $5.75 $175,643 - $283,693	-49,338 Reduced 12.61%	341,794 $1.97 Million
Q3 2023 Nov 14, 2023	BUY	$3.56 - $5.75 $842,253 - $1.36 Million	236,588 Added 224.88%	341,794 $1.97 Million
Q2 2023 May 14, 2024	SELL	$3.51 - $4.69 $873,733 - $1.17 Million	-248,927 Reduced 70.29%	105,206 $382,000
Q2 2023 Aug 14, 2023	SELL	$3.51 - $4.69 $873,733 - $1.17 Million	-248,927 Reduced 70.29%	105,206 $382,000
Q1 2023 May 14, 2024	BUY	$3.58 - $6.3 $132,123 - $232,507	36,906 Added 11.63%	354,133 $1.53 Million
Q1 2023 May 11, 2023	BUY	$3.58 - $6.3 $132,123 - $232,507	36,906 Added 11.63%	354,133 $1.53 Million
Q4 2022 May 14, 2024	BUY	$3.18 - $7.0 $52,129 - $114,751	16,393 Added 5.45%	317,227 $2.22 Million
Q4 2022 Feb 13, 2023	BUY	$3.18 - $7.0 $52,129 - $114,751	16,393 Added 5.45%	317,227 $2.22 Million
Q3 2022 May 14, 2024	BUY	$2.37 - $4.28 $600,159 - $1.08 Million	253,232 Added 531.98%	300,834 $1.09 Million
Q3 2022 Nov 10, 2022	BUY	$2.37 - $4.28 $600,159 - $1.08 Million	253,232 Added 531.98%	300,834 $0
Q2 2022 May 14, 2024	SELL	$1.23 - $3.25 $422,541 - $1.12 Million	-343,530 Reduced 87.83%	47,602 $155,000
Q2 2022 Aug 15, 2022	SELL	$1.23 - $3.25 $459,786 - $1.21 Million	-373,810 Reduced 88.7%	47,602 $155,000
Q1 2022 May 16, 2022	BUY	$2.0 - $3.28 $617,932 - $1.01 Million	308,966 Added 274.77%	421,412 $843,000
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $94,454 - $154,917	30,081 Added 36.52%	112,446 $354,000
Q3 2021 Nov 10, 2021	BUY	$4.89 - $7.12 $402,764 - $586,438	82,365 New	82,365 $403,000

Others Institutions Holding WVE

# of Institutions

215

Shares Held

133M

Call Options Held

1.22M

Put Options Held

616K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $600M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Wave Life Sciences Ltd. Transaction History